<?php include 'include/header.php';
include 'include/navbar.php';
?>

<!-- Page Header Start -->
<div class="container-fluid page-header py-5 mb-5 wow fadeIn" data-wow-delay="0.1s">
    <div class="container py-5">
        <h1 class="display-3 text-white animated slideInRight">Guidelines</h1>
        <nav aria-label="breadcrumb">
            <ol class="breadcrumb animated slideInRight mb-0">
                <li class="breadcrumb-item"><a href="#">Home</a></li>
                <!-- <li class="breadcrumb-item"><a href="#">Pages</a></li> -->
                <li class="breadcrumb-item active" aria-current="page">Guidelines</li>
            </ol>
        </nav>
    </div>
</div>
<!-- Page Header End -->


<!-- About Start -->
<div class="container-xxl py-5">
    <div class="container">
        <div class="row g-5">

            <div class="col-lg-12 wow fadeIn" data-wow-delay="0.5s">


                <p class="fw-medium text-uppercase text-primary mb-2">General Guidelines</p>
                <p class="mb-4"> <i class="fas fa-chevron-circle-right" aria-hidden="true"></i> Abstract submission is open to all registered delegates. </p>
                <p class="mb-4"><i class="fas fa-chevron-circle-right" aria-hidden="true"></i> Abstracts should be submitted only online through the "Abstract submission portal" on the official site www.dermazonesouth2023.com </p>
                <p class="mb-4"><i class="fas fa-chevron-circle-right" aria-hidden="true"></i> You may submit more than one abstract in each category. But a maximum of only one oral presentation would be accepted per delegate, other submissions from the same delegate will be converted to e-poster if found suitable. </p>
                <p class="mb-4"><i class="fas fa-chevron-circle-right" aria-hidden="true"></i> The scientific committee will evaluate the submitted abstracts based on the following criteria: the novelty of the research, the significance of the case report/study, clarity, and the succinct manner in which the abstracts are written </p>
                <p class="mb-4"><i class="fas fa-chevron-circle-right" aria-hidden="true"></i> The scientific chairperson and committee members take the final call on abstracts. </p>
                <p class="mb-4"><i class="fas fa-chevron-circle-right" aria-hidden="true"></i> Acceptance or rejection of the paper will be conveyed by email two weeks after the last date. </p>
                <p class="mb-4"><i class="fas fa-chevron-circle-right" aria-hidden="true"></i> If a revision is needed, the revised abstract should be sent back within a week. </p>
                </br>
                <p class="fw-medium text-uppercase text-primary mb-2">Abstract Preparation Guidelines</p>
                <p class="mb-4"> <i class="fas fa-long-arrow-alt-right" aria-hidden="true"></i> Oral paper presentation </p>
                <p class="mb-4"><i class="fas fa-long-arrow-alt-right" aria-hidden="true"></i> E-Poster presentation </p>

                </br>
                <p class="fw-medium text-uppercase text-primary mb-2">Submission Categories </p>
                <div class="row">
                    <!-- <div class="col-3"><img class="img-fluid m-3" src="img/guideline-cat.jpg" width="100%">  </div> -->
                    <div class="col-12">
                        <h5 class="mt-4 "> We welcome submissions related to one of the following sub-themes, and we would be glad if you could mention the sub-theme in which you would like your abstract to be considered. </h5>
                    </div>
                </div>


                </br>

                <div class="row">
                    <div class="col-4">
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Pigmentary disorders </p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Papulosquamous disorders </p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Immunobullous disorders</p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Pediatric dermatoses</p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Infections </p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Adnexal disorders</p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Aesthetic dermatology</p>

                    </div>
                    <div class="col-4">
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Sexually transmitted disorders</p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Leprosy</p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Genodermatoses</p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Contact dermatitis </p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Vasculitis</p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Onco-dermatology</p>
                        <p class="mb-4"><i class="fa fa-circle text-primary" aria-hidden="true"></i> Miscellaneous/others</p>

                    </div>

                    <div class="col-4">
                        <img class="img-fluid" src="img/guideline.jpg" alt="" height="100%">
                    </div>
                </div>


                <p> • The abstract should be properly structured and checked for spelling and grammar </p>
                <p>• The word limit for the abstract is 250 words (Excluding the title, authors, and affiliations)</p>
                <p>• The abstract font should be in Times New Roman, and size 12 point. The text line spacing should be double spaced</p>
                <p>• Abstract for original study should be in the following order: Title, Objective, methodology, concise results, conclusion, and limitations if any</p>
                <p>• Abstract for case reports and case series should be in the following order: Title, case history, concise discussion, and conclusion</p>
                <p>• The author's name, affiliation, address, mobile number, and email address should not be mentioned in the abstract to ensure a blinded review. All the identifying features of the authors should be mentioned online while doing the submission</p>
                <p>• The title should be brief and self-explanatory</p>
                <p>• Avoid using graphs, figures, tables, or references in the abstract</p>
                <p>• The use of abbreviations and acronyms should be limited in the abstract</p>
                <p>• The submitted abstract should not have been presented previously at conferences or published in the literature</p>
                <p>• Use generic names of drugs or their active pharmacological content, avoiding the commercial names of the drug/or companies</p>
                <p>• The scientific committee team will decide on whether the oral presentation is award paper or free paper presentation</p>
                <p>• Non-adherence to the guideline may result in an automatic rejection of the abstract</p>
                <p>• Abstract once submitted cannot be modified</p>
                <p>• For abstract submission, Please visit www.dermazonesouth2023.com</p>
                <p>• Once uploaded successfully, you will duly receive an acknowledgment</p>
                <p>• Please check the conference website for regular updates. </p>
                <p class="mb-4"> <strong>Abstract submission closes on 20.08.2023 </strong> </p>


            </div>

        </div>
    </div>
</div>
<!-- About End -->

<?php include 'include/footer.php'; ?>